Friday 6 November 2026 Export JAZZ’s income statement to Excel — free account

Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals PLC’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 4.88% from fiscal 2024.

Revenue: +10.4%
EPS: −280.5%
Free cash flow: −60.4%
Total debt: +3.88%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

235.47 8.15 +3.59%

Follow JAZZ

Alert me

Market cap: $14.6B
P/E: 62.6×
Fwd P/E: 35.9×
Dividend yield: —
F-score: 5/9
Altman Z: 1.37
Beneish M: −3.03
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Jazz Pharmaceuticals PLC (JAZZ) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Jazz Pharmaceuticals PLC (JAZZ) trades at a P/B ratio of 3.5×. Over the past ten years it has ranged from 1.4× (May 2025) to 8.8× (April 2015); the current reading is higher than 73% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/JAZZ/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Jazz Pharmaceuticals PLC P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/JAZZ/metrics/pb-ratio">Jazz Pharmaceuticals PLC (JAZZ) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	2.4×	29.05%
FY2024	1.9×	(13.47%)
FY2023	2.1×	(32.16%)
FY2022	3.2×	65.23%
FY2021	1.9×	(23.67%)
FY2020	2.5×	(7.73%)
FY2019	2.7×	1.00%
FY2018	2.7×	(11.29%)
FY2017	3.0×	(15.38%)
FY2016	3.6×	(33.28%)

Period	P/B ratio	Change
Sep 2026	3.6×	12.67%
Jun 2026	3.2×	22.84%
Mar 2026	2.6×	7.56%
Dec 2025	2.4×	18.79%
43 more quarters	Free account

Against its own ten years

Low 1.4× High 8.8×

Ten-year median 2.7×

Current reading's percentile 80

Company	P/B ratio
HALO Halozyme Therapeutics, Inc. compare	n/m
BBIO BridgeBio Pharma, Inc. compare	n/m
BMRN BioMarin Pharmaceutical Inc. compare	1.7×
JAZZ Jazz Pharmaceuticals PLC	3.5×
TECH Bio-Techne Corp compare	5.4×
KYMR Kymera Therapeutics, Inc. compare	7.8×
EXEL Exelixis, Inc. compare	9.3×
ASND Ascendis Pharma A/S compare	9.8×
SMMT Summit Therapeutics PLC compare	17.8×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Jazz Pharmaceuticals PLC (JAZZ) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on JAZZ

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on JAZZ

Stockrow Weekly